BioTeSys' colleagues regularly appears as speaker at public events and publish scientific articles. Information on those events and release notes, as well as company announcements can be found here at a glance.
BioTeSys joins in with the change from a petroleum-based economy to a sustainable, bio-based economy. BioTeSys will contribute especially its analytical skills regarding botanicals
NDA Panel member Hans Verhagen comments on actual ‘good science’ and necessary trial designs to successfully pass the EFSA evaluation process on health claims.
The test laboratory for biological and chemical analyses, cell-based test systems and study site have been proved to offer highest quality for eleven years now.
The Nutritional CRO and Test laboratory goes online with a completely restructured website. The bilingual web presentation informs companies in the food, cosmetics, and medical devices industries about the three business fields analytics, in vitro, and clinical trials.
Constipation is one of the most common health impairments in Western countries. The Nutritional CRO of BioTeSys highlights methods to analyze effects of functional food and dietary supplements on digestive health.
The new digital data analysis system A.B.O.S. offers rapid detection, classification and evaluation of
biological characteristics or processes in complex data sets.
The automated assay FADU measures genotoxic effects by detecting DNA strand breaks.
BioTeSys selects Logos Technologies ALPHADAS® eSource and pro-active EDC system to give clients real time access to study data.
BioTeSys becomes a member of IVTIP (In Vitro Testing Industrial Platform) to exchange ideas and discuss state of the art science and technology.
Quality through standards-following that principle BioTeSys obtains the certification.